Matsakaici na Apixaban CAS 545445-44-1 Tsafta > 98.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. shine babban kamfani na 3-Morpholino-1- (4- (2-Oxopiperidin-1-yl) phenyl) -5,6-Dihydropyridin-2 (1H) -daya (CAS: 545445). -44-1) tare da babban inganci, matsakaici na Apixaban (CAS: 503612-47-3).Ruifu Chemical na iya samar da isar da saƙo na duniya, farashi mai gasa, kyakkyawan sabis, ƙanana da adadi mai yawa akwai.Sayi Apixaban Intermediates,Please contact: alvin@ruifuchem.com
| Sunan Sinadari | 3-Morpholino-1- (4- (2-Oxopiperidin-1-yl) phenyl) -5,6-Dihydropyridin-2 (1H) -daya |
| Makamantu | Apixaban Intermediate 1;5,6-Dihydro-3- (4-Morpholinyl) -1- [4- (2-Oxo-1-Piperidinyl) phenyl] -2 (1H) -Pyridinone;5-Morpholin-4-yl-1-[4- (2-Oxopiperidin-1-yl) phenyl] -2,3-Dihydropyridin-6-daya;Apixaban Impurity A |
| Matsayin Hannun jari | A Stock, Kasuwancin Kasuwanci |
| Lambar CAS | 545445-44-1 |
| Tsarin kwayoyin halitta | Saukewa: C20H25N3O3 |
| Nauyin Kwayoyin Halitta | 355.43 g/mol |
| Matsayin narkewa | > 199 ℃ (Dec.) |
| Yawan yawa | 1.267 g/ml |
| COA & MSDS | Akwai |
| Asalin | Shanghai, China |
| Kashi | Matsakaicin Apixaban (CAS: 503612-47-3) |
| Alamar | Ruifu Chemical |
| Abubuwa | Ƙayyadaddun bayanai | Sakamako |
| Bayyanar | Hasken Rawaya Foda | Hasken Rawaya Foda |
| Asara akan bushewa | <0.50% | 0.16% |
| Ragowa akan Ignition | <0.20% | 0.07% |
| Tsarkake / Hanyar Bincike | >98.0% (Yankin HPLC) | 99.12% |
| Duk wani Rashin Tsabtace Mutum | <0.50% | <0.50% |
| Jimlar ƙazanta | <2.00% | 0.88% |
| 1H NMR Spectrum | Daidai da Tsarin | Ya dace |
| LC-MS don ganewa | Ya dace | Ya dace |
| Kammalawa | An gwada samfurin kuma ya dace da ƙayyadaddun da aka bayar | |
| Aikace-aikace | Matsakaicin Apixaban (CAS: 503612-47-3) | |
Kunshin:Fluorinated Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye akwati sosai kuma a adana a cikin sanyi, busasshe kuma mai cike da iska daga abubuwan da ba su dace ba.Kare daga haske da danshi.
Jirgin ruwa:Isar da shi zuwa duniya ta iska, ta FedEx / DHL Express.Bayar da isarwa cikin sauri kuma abin dogaro.
Yadda ake siya?Da fatan za a tuntuɓiDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Kwarewar Shekaru 15?Muna da fiye da shekaru 15 na gwaninta a cikin ƙira da fitarwa na matsakaicin matsakaicin magunguna masu inganci ko sinadarai masu kyau.
Manyan Kasuwanni?Sayarwa zuwa kasuwannin cikin gida, Arewacin Amurka, Turai, Indiya, Koriya, Jafananci, Australia, da sauransu.
Fa'idodi?Babban inganci, farashi mai araha, sabis na ƙwararru da tallafin fasaha, bayarwa da sauri.
inganciTabbaci?Tsananin kula da ingancin inganci.Kayan aikin ƙwararru don bincike sun haɗa da NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, gwajin ƙayyadaddun ƙwayoyin cuta, da sauransu.
Misali?Yawancin samfurori suna ba da samfurori kyauta don ƙima mai kyau, farashin jigilar kaya ya kamata a biya ta abokan ciniki.
Binciken Masana'antu?Ma'aikata duba maraba.Da fatan za a yi alƙawari a gaba.
MOQ?Babu MOQ.Karamin tsari abin karɓa ne.
Lokacin Bayarwa? Idan cikin hannun jari, garantin isar da kwana uku.
Sufuri?By Express (FedEx, DHL), ta Air, ta Teku.
Takardu?Bayan sabis na tallace-tallace: COA, MOA, ROS, MSDS, da dai sauransu za a iya ba da su.
Tsarin al'ada?Zai iya ba da sabis na haɗawa na al'ada don dacewa da buƙatun bincikenku.
Sharuɗɗan Biyan kuɗi?Za a fara aiko da daftari na Proforma bayan tabbatar da oda, an rufe bayanan bankin mu.Biya ta T/T (Telex Transfer), PayPal, Western Union, da dai sauransu.
3-Morpholino-1- (4- (2-Oxopiperidin-1-yl) phenyl) -5,6-Dihydropyridin-2 (1H) -daya (CAS: 545445-44-1) shine matsakaici na Apixaban (CAS: 503612-47-3).
Apixaban sabon nau'in mai hana factor Xa factor ne tare da Bristol-Myers Squibb da Pfizer suka haɓaka.Sunan kasuwanci shine Eratol, wanda shine sabon nau'in maganin ciwon ciki na baka.Ta hanyar hana wani muhimmin coagulation factor Xa, Apixaban zai iya hana thrombin samar da thrombosis.A ranar 26 ga Afrilu, 2007, Bristol-Myers Squibb ya haɗa hannu tare da Pfizer don sanar da haɗin gwiwa a cikin haɓaka sabon maganin maganin jijiyoyi na baki Apixaban mallakar Bristol-Myers Squibb a matsayin ingantaccen madadin Warfarin.A cikin watan Mayu 2011, Apixaban shine farkon wanda ya amince da rigakafin thrombosis na jijiyoyi a cikin manya marasa lafiya da ke fuskantar zaɓaɓɓen hip ko gwiwa a cikin ƙasashen 27 EU, Iceland da Norway.A ranar 20 ga Nuwamba, 2012, Hukumar Tarayyar Turai ta amince da Ererto (Apixaban) don rigakafin bugun jini da bugun jini a cikin tsofaffi marasa lafiya tare da ƙananan ƙwayar ƙwayar cuta (NVAF) tare da ɗaya ko fiye da abubuwan haɗari.Bayan haka, Hukumar Abinci da Magunguna ta Kanada, Japan, da FDA ta Amurka sun amince da Ererto (Apixaban) don rigakafin bugun jini da bugun jini a cikin manya marasa lafiya waɗanda ba su da fibrillation na valvular (NVAF) tare da abubuwan haɗari ɗaya ko fiye.A ranar 12 ga Afrilu, 2013, an ba da sanarwar cewa za a jera sabon magani na Eloto (ELIQUIS) (Apixaban) tare da haɗin gwiwar Bristol-Myers Squibb da Pfizer a cikin kasar Sin.
![Apixaban Intermediate CAS 27143-07-3 Ethyl Chloro [(4-Methoxyphenyl) hydrazono] acetate tsarki ≥99.0% (HPLC)](https://www.ruifuchemical.com/uploads/Apixaban-Intermediate-CAS-490-46-0-Factory-Shanghai-Ruifu-Chemical-Co.-Ltd.-www.ruifuchem.com_-300x300.jpg)
